VIRGINIAMYCIN M1

CAS: 21411-53-0

Ref. IN-DA00BC45

Produktinformation

• Name: VIRGINIAMYCIN M1
• Synonyme: [u'Ostreogrycin G', u'Pristinamycin IIA', u'Pristinamycin IIB', u'Staphylomycin M', u'Staphylomycin M1', u'Streptogramin A', u'Virginiamycin Factor M1', u'Virginiamycin IIB', u'Streptogramin A', u'Mikamycin A', u'Pristinamycin IIA', u'Ostreogrycin a', u'UNII-8W4UOL59AZ', u'8W4UOL59AZ', u'21411-53-0', u'Virginiamycin Factor M1', u'CHEBI:9997', u'NSC 244426', u'VERNAMYCIN A', u'Staphylomycin M1', u'NSC87434', u'EINECS 244-376-6', u'NSC 87432', u'Factor M', u'Virginiamycin M1-dx', u'Antibiotic PA 114A1', u'Vernamycin A & B mixture', u'Virginiamycin M1 (90%)', u'SCHEMBL673193', u'CHEMBL1236670', u'PA 114A', u'DAIKHDNSXMZDCU-FQTGFAPKSA-N', u'8,9,14,15,24,25-Hexahydro-14-hydroxy-3-isopropyl-4,12-dimethyl-3H-21,18-nitrilo-1H,22H-pyrrolo(2,1-c)(1,8,4,19)dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone', u'8,9,14,15,24,25-Hexahydro-14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-3H-21,18-nitrilo-1H,22H-pyrrolo(2,1-c)(1,8,4,19)dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone', u'MFCD00869411', u'NSC-87434', u'Vernamycin A & vernamycin B (1:1)', u'DB01669', u'Vernamycin A, mixture with vernamycin B', u'RP 12536', u'VERNAMYCIN A & B MIXTURE (1:1)', u'LS-187695', u'C11299', u'C-23077', u'UNII-4O8O7Q7IU4 component DAIKHDNSXMZDCU-FQTGFAPKSA-N', u'(3R,4R,5E,10E,12E,14S)-14-hydroxy-3-isopropyl-4,12-dimethyl-8,9,14,15,24,25-hexahydro-1H,3H,22H-21,18-(azeno)pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone', u'(3R,4R,5E,10E,12E,14S)-14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-8,9,14,15,24,25-hexahydro-1H,3H,22H-21,18-(azeno)pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone', u'(3R,4R,5E,10E,12E,14S)-8,9,14,15,24,25-Hexahydro-14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-3H-21,18-nitrilo-1H,22H-pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone', u'Staphylomycin', u'Virginiamycin M', u'VIRGINIAMYCINM1', u'VIR'], (3R,4R,5E,10E,12E,14S)-14-hydroxy-4,12-dimethyl-3-(propan-2-yl)-8,9,14,15,24,25-hexahydro-1H,3H,22H-21,18-(azeno)pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone, (3R,4R,5E,10E,12E,14S)-8,9,14,15,24,25-Hexahydro-14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-3H-21,18-nitrilo-1H,22H-pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone, (3R,4R,5E,14S)-14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-8,9,14,15,24,25-hexahydro-1H,3H,22H-21,18-(azeno)pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone, (3R,4R,5Z,10Z,12Z,14S)-14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-8,9,14,15,24,25-hexahydro-1H,3H,22H-21,18-(azeno)pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone, (3S,4S,5Z,10Z,12Z,14R)-14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-8,9,14,15,24,25-hexahydro-1H,3H,22H-21,18-(azeno)pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone, 14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-8,9,14,15,24,25-hexahydro-1H,3H,22H-21,18-(azeno)pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone, 3H-21,18-Nitrilo-1H,22H-pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone, 8,9,14,15,24,25-hexahydro-14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-, (3R,4R,5E,10E,12E,14S)-, 8,9,14,15,24,25-Hexahydro-14-hydroxy-3-isopropyl-4,12-dimethyl-3H-21,18-nitrilo-1H,22H-pyrrolo(2,1-c)(1,8,4,19)dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone, 8,9,14,15,24,25-Hexahydro-14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-3H-21,18-nitrilo-1H,22H-pyrrolo(2,1-c)(1,8,4,19)dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone, Antibiotic PA 114A, Antibiotic PA 114A1, Factor M, Factor M (antibiotic), Mikamycin A, Nsc 244426, Nsc 87432, Ostreogrycin a, Pa 114A, Pristinamycin II, Pristinamycin II_A, Rp 12536, Staphylomycin M₁, Streptogramin A, Vernamycin A, Virginiamycin M₁, Virginiamycin factor M1, [3R-(3R*,4R*,5E,10E,12E,14S*)]-8,9,14,15,24,25-Hexahydro-14-hydroxy-4,12-dimethyl-3-(1-methylethyl)-3H-21,18-nitrilo-1H,22H-pyrrolo[2,1-c][1,8,4,19]dioxadiazacyclotetracosine-1,7,16,22(4H,17H)-tetrone, Virginiamycin M1
• Marke: Indagoo

Chemische Eigenschaften

• Molekulargewicht: 525.5934
• Formel: C₂₈H₃₅N₃O₇
• Reinheit: 97%
• Farbe/Form: Solid
• InChl: InChI=1S/C28H35N3O7/c1-17(2)26-19(4)9-10-24(34)29-11-5-7-18(3)13-20(32)14-21(33)15-25-30-22(16-37-25)27(35)31-12-6-8-23(31)28(36)38-26/h5,7-10,13,16-17,19-20,26,32H,6,11-12,14-15H2,1-4H3,(H,29,34)/b7-5+,10-9+,18-13+/t19-,20-,26-/m1/s1
• InChI Key: DAIKHDNSXMZDCU-FQTGFAPKSA-N